Ying Huang
Stock Analyst at B of A Securities
(2.35)
# 2,438
Out of 4,842 analysts
38
Total ratings
50%
Success rate
8.94%
Average return
Main Sectors:
Stocks Rated by Ying Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $555 → $567 | $447.09 | +26.82% | 12 | Mar 31, 2025 | |
| GILD Gilead Sciences | Maintains: Neutral | $70 → $72 | $111.11 | -35.20% | 8 | Feb 5, 2020 | |
| RDUS Radius Recycling | Maintains: Buy | $51 → $47 | $29.53 | +59.16% | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | $64 → $80 | $8.97 | +791.86% | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $0.87 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $34 → $40 | $2.52 | +1,487.30% | 2 | Mar 8, 2018 | |
| BLUE bluebird bio | Maintains: Neutral | $3,700 → $4,360 | $4.97 | +87,626.36% | 1 | Feb 22, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $135 → $115 | $3.38 | +3,302.37% | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $0.63 | - | 4 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | $358 → $365 | $132.75 | +174.95% | 1 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $33 | $1.19 | +2,684.81% | 1 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $283.54 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Mar 31, 2025
Maintains: Buy
Price Target: $555 → $567
Current: $447.09
Upside: +26.82%
Gilead Sciences
Feb 5, 2020
Maintains: Neutral
Price Target: $70 → $72
Current: $111.11
Upside: -35.20%
Radius Recycling
Jul 25, 2018
Maintains: Buy
Price Target: $51 → $47
Current: $29.53
Upside: +59.16%
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: $64 → $80
Current: $8.97
Upside: +791.86%
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.87
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: $34 → $40
Current: $2.52
Upside: +1,487.30%
bluebird bio
Feb 22, 2018
Maintains: Neutral
Price Target: $3,700 → $4,360
Current: $4.97
Upside: +87,626.36%
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: $135 → $115
Current: $3.38
Upside: +3,302.37%
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.63
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: $358 → $365
Current: $132.75
Upside: +174.95%
Sep 22, 2017
Maintains: Buy
Price Target: $23 → $33
Current: $1.19
Upside: +2,684.81%
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $283.54
Upside: -